Effect of desferrioxamine cardioplegia on ischemia-reperfusion injury in isolated rat heart

Annals of Thoracic Surgery

Volumn 63, Issue 4, 1997, Pages 1003-1011

  Nicholson, Sonia C ^a   Squier, Marian ^a   Ferguson, David J P ^a   Nagy, Zsuzsanna ^a   Westaby, Stephen ^a   Evans, Rhys D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HISTOCHEMISTRY; ISOLATED HEART; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; DEFEROXAMINE; DIASTOLE; HEART ARREST, INDUCED; LACTIC ACID; MALE; MICROSCOPY, ELECTRON; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, WISTAR; SIDEROPHORES;

EID: 0030889577     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)01386-0     Document Type: Article

References (21)

1. Ferreira R, Burgos M, Milei J, et al. Effect of supplementing cardioplegic solution with deferoxamine on reperfused human myocardium. J Thorac Cardiovasc Surg 1990;100:708-14.
2. Drossos G, Lazou A, Panagopoulos P, Westaby S. Deferoxamine cardioplegia reduces superoxide radical production in human myocardium. Ann Thorac Surg 1995;59:169-72.
3. Van Jaarsveld H, Potgieter GM, Kuyl JM, Barnard HC, Barnard SP. The effect of desferal on rat heart mitochondrial function, iron content, and xanthine dehydrogenase/oxidase conversion during ischemia-reperfusion. Clin Biochem 1990; 23:509-13.
4. Menasché P, Grousset C, Gauduel Y, Mouas C, Piwnica A. Prevention of hydroxyl radical formation: a critical concept for improving cardioplegia. Circulation 1987;76(Suppl 5): 180-5.
5. Karwatowska-Prokopczuk E, Czarnowska E, Beresewicz A. Iron availability and free radical induced injury in the isolated ischaemic/reperfused rat heart. Cardiovasc Res 1992;26:58-66.
6. Bernier M, Hearse DJ, Manning AS. Reperfusion-induced arrhythmias and oxygen-derived free radicals. Circ Res 1986; 58:331-40.
7. DeBoer DA, Clark RE. Iron chelation in myocardial preservation after ischemia-reperfusion injury: the importance of pretreatment and toxicity. Ann Thorac Surg 1992;53:412-8.
8. Ferrari R, Ceconi C, Curello S, Cargnoni A, Medici D. Oxygen free radicals and reperfusion injury; the effect of ischemia and reperfusion on the cellular ability to neutralise oxygen toxicity. J Mol Cell Cardiol 1986;18(Suppl 4):67-9.
9. Ambrosio G, Zweier JL, Jacobus WE, Weisfeldt ML, Flaherty JT. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation 1987;76:906-15.
10. Badylak SF, Simmons A, Turek J, Babbs CF. Protection from reperfusion injury in the isolated rat heart by postischaemic deferoxamine and oxypurinol administration. Cardiovasc Res 1987;21:500-6.
11. Kikugawa K, Kojima T, Kosugi H. Major thiobarbituric acid-reactive substances of liver homogenate are alkadienals. Free Radic Res Commun 1990;8:107-13.
12. Weiss JL, Frederiksen JW, Weisfeldt ML. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 1976;58:751-60.
13. Hohorst HJ. L-(+)-lactate. In: Bergmeyer HU, ed. Methods of enzymatic analysis. New York: Academic, 1963:215-9.
14. Lapenna D, Porreca E, Del Boccio G, et al. Regional distribution of glutathione-related antioxidant differences in the normal rabbit aorta. Life Sci 1991;48:2225-8.
15. Mack CP, Brosamer KM, Shlafer M. Ultrastructural demonstration of peroxidative activity and peroxidation in ischaemic and ischaemic-reperfused rabbit hearts. Cardiovasc Res 1993;27:371-6.
16. Bonow RO, Bacharach SL, Green MV, et al. Impaired left ventricular diastolic filling in patients with coronary artery disease, assessment with radionuclide angiography. Circulation 1981;64:315-23.
17. Maxwell MP, Hearse DJ, Yellon DM. Inability of desferrioxamine to limit tissue injury in the ischaemic and reperfused rabbit heart. J Cardiovasc Pharmacol 1989;13:608-15.
18. Vaughan DM, Koke JR, Bittar N. Ultrastructure, peroxisomes and lipid peroxidation in reperfused myocardium. Cytobios 1988;55:71-80.
19. Yanagiya N. Ultrastructural and histochemical changes of mitochondria in global ischemic cardiac muscle of rat. Cell Mol Biol 1994;40:1151-64.
20. Tribulova N, Slezak J, Ravingerova T, Styk J, Gabauer I. Vulnerability of specialized conductive tissue to ischemia and reperfusion related injury. Bratisl Lek Listy 1991;92: 81-90.
21. Lurie KG, Argentieri TM, Sheldon J, Frame LH, Matschinsky FM. Metabolism and electrophysiology in subendocardial Purkinje fibers after infarction. Am J Physiol 1987;253: H662-70.